System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Eric Schulze-Bahr is an expert in Cardiology at University Hospital Münster (Germany). As of October 2026, ScienceLeadR ranks Eric Schulze-Bahr in the top 1% of experts worldwide for Cardiac Conduction System Disease, Cardiovascular Abnormalities and Congenital Abnormalities. Eric Schulze-Bahr has authored 270 publications, the most recent in 2026, and is an investigator in 1 clinical trial, 1 of them ongoing. SLR score: 857 (community average: 125). How the SLR is computed.

LeadR Profile

Eric Schulze-Bahr University Hospital Münster Germany
857 ScienceLeadR Reputation 857

Unlock

Register Login
Network Map

Cardiology

Subspecialties: Genetics - Biochemistry - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1995 - 2026
Source: PubMed

ERN GUARD-Heart

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 270

Citations

Citations: 21 117 1st author: 25 Last author: 57 Unique author: 10

Main journals

Heart Rhythm 22
Circulation 18
Europace 14
Eur Heart J 13
Herzschrittmacherther Elektrophysiol 9

Best Journals

Eur Heart J 5
N Engl J Med 2
Nat Genet 2

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
The p.Arg52Leu variant in GNB2 causes a gain-of-function due to an increase of I K, ACh in stimulated hiPSC-CMs.
PMID 42834367 — cells, genes, microscopy, electron, scanning transmission, pluripotent stem cells, cardiovascular diseases, stem cells, cell line, induced pluripotent stem cells		BMC Cardiovasc Disord20260
Brugada Syndrome in the Pediatric Population: Diagnostic Challenges and Clinical Outcome-Results of the German Multicenter Study COGIA.
PMID 42669184 — genetics, diagnosis, therapeutics, brugada syndrome, child		J Cardiovasc Electrophysiol20260
Polygenic risk modulates myocardial repolarization and T-wave geometry in congenital long-QT syndrome type 1: evidence from digital ECG phenotyping.
PMID 42111135 — genes, romano-ward syndrome, phenotype, polymorphism, single nucleotide, long qt syndrome, genetic risk score		Front Cardiovasc Med20260
Clinical Profile and Mode of Initiation of Spontaneous Ventricular Tachyarrhythmias in Patients With Brugada Syndrome (START-BrS).
PMID 41979546 — tachycardia, ventricular, ventricular premature complexes, pharmaceutical preparations, arrhythmias, cardiac, cardiovascular diseases, tachycardia, brugada syndrome		JACC Clin Electrophysiol20260
A MATLAB Algorithm to Automatically Estimate the QT Interval and Other ECG Parameters and Validation Using a Machine Learning Approach in Congenital Long-QT Syndrome.
PMID 41028332 — algorithms, machine learning, learning, long qt syndrome		J Cardiovasc Transl Res20250

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 1

By status:

Recruiting 1

By type:

Observational 1

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 0
multicentric5to9 0
multicentricup10 1

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Non interventional Study of Seroprevalence of Pre existing Antibodies Against Adenovirus associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2) Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
NCT06311708 — genes, antibodies, adenoviridae, heart failure, heart, arrhythmogenic right ventricular dysplasia, viruses, satellite viruses, therapeutics, plakophilins, mutation, cardiomyopathies		N/ARecruiting2023

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS